Global Migraine Market: Industry Analysis & Outlook (2019-2023)

The U.S. held the major share in the global migraine market. The rising migraine population in the U.S. is inducing high demand for proper medication, which in turn drives the U.S. migraine market towards higher verticals.
By: Koncept Analytics
 
 
Spread the Word
Listed Under

Tag:
* Global Migraine Market

Industry:
* Reports

Location:
* Delhi - Delhi - India

Subject:
* Reports

DELHI, India - April 19, 2019 - PRLog -- Migraine is a neurological disorder involving nerve pathways and brain chemicals. It is characterized by a severe throbbing recurring pain on one side of the head. Nausea, visual imparity and sensitivity to light & sound are common symptoms of migraine. There are different types of migraines that are usually identified by its predominant symptoms. Generally, migraine can be chronic or episodic, depending upon the duration of headaches. Migraine usually acompasses through four stages: Prodrome, Aura, Headaches and Post-drome. Drugs for migraine headaches can relieve the pain and symptoms of a migraine attack and help prevent further migraine attacks. Migraine can be treated with two types of drugs: abortive and preventive that depends upon the intensity of a migraine attack.

The global migraine market has grown considerably over last few years. Different preventative drugs were launched by various biotech and pharmaceuticals firms and a lot more are under a development process. Factors such as increasing female population, rising health expenditure, accelerating economic growth, increasing cigarette consumption, rising prevalence of migraine and unmet medical needs have driven the global migraine market. The new CGRP drugs are expected to push the global migraine market growth in future.

The U.S. held the major share in the global migraine market. The rising migraine population in the U.S. is inducing high demand for proper medication, which in turn drives the U.S. migraine market towards higher verticals. The adoption of migraine treatment though the CGRP drugs is expected to grow the U.S. migraine market further.

The global migraine market is dominated by four key players such as Eli Lily and Co., Amgen Inc., Teva Pharmaceuticals and Alder Biopharmaceuticals. Their upcoming launches of migraine preventative drugs are expected to change the scenario of the overall migraine treatments. Furthermore, these leading players are consistently directing their strategic efforts to boost up the growth of the global migraine market.

List of Figures

Types of Migraine
Diagnosis Procedures
Global Migraine Market by Value (2014-2018)
Global Migraine Market Forecast by Value (2019-2023)
Global Migraine Market by Drug Type (2018)
Global Therapeutic Botulinum Toxin Market Forecast by Value (2018-2023)
Global Erenumab Drug Revenue Forecast (2019-2023)
Global Galcanezumab Drug Revenue Forecast (2019-2023)
Global Fremanezumab Drug Revenue Forecast (2019-2023)
Global Eptinezumab Drug Revenue Forecast (2020-2023)
The U.S. Total Migraine Population Forecast (2018-2023)
The U.S. Total Diagnosed Migraine Population Forecast (2018-2023)
The U.S. Diagnosed and Treated Adult Migraine Population Forecast (2018-2023)
The U.S. Migraine Treatment by Specialty (2018)
The U.S. Migraine Treated Population by Drug Type (2018)
The U.S. Diagnosed Adult Migraine Population with Triptan Treatment Forecast (2018-2023)
The U.S. Migraine Prophylaxis Market by Treatment (2018)
The U.S. Diagnosed Adult Migraine Population with Acute Treatment Forecast (2018-2023)
The U.S. Erenumab Drug Revenue and Treated Patients Forecast (2019-2023)
The U.S. Galcanezumab Drug Revenue and Treated Patients Forecast (2019-2023)
The U.S. Fremanezumab Drug Revenue and Treated Patients Forecast (2019-2023)
Europe Total Migraine and Diagnosed Population Forecast (2018-2023)
Global Female Population (2014-2018)
Global Cigarette Consumption (2014-2018)
Global GDP Per Capita (2014-2018)
Global Healthcare Spending Per Capita (2014-2018)
Key Players – Market Cap Comparison
Key Players – Revenue Comparison (2018)
Key Players – R&D Comparison (2018)
Eli Lilly and Company Revenue by Segments (2018)
Eli Lilly and Company Revenue and Net Income (2014-2018)
Eli Lilly and Company Research and Development Expenditure (2016-2018)
Amgen Inc. Total Revenue by Geographic Region (2018)
Amgen Inc. Total Revenue and Net Income (2014-2018)
Amgen Inc. Research and Development Expenditure (2016-2018)
Teva Pharmaceuticals Revenue by Segments (2018)
Teva Pharmaceuticals Revenue and Net Income (2014-2018)
Teva Pharmaceuticals R&D Expenditure (2016-2018)
Alder Biopharmaceuticals Revenue and Net Income (2014-2018)
Alder Biopharmaceuticals Research & Development Expenditure (2016-2018)

List of Tables

Difference between Episodic and Chronic Migraine
Stages of Migraine
Progressing CGRP - Targeting Drug Pipeline
Branded Acute Treatment for Episodic Migraine
Key Players - The U.S. CGRP Drugs for Episodic Migraine Market Penetration Forecast (2018-2023)
Key Players - The U.S. CGRP Drugs Chronic Migraine Market Share Forecast (2018-2023)
Alder Pharmaceuticals Pipeline Overview (2018)

For more Information:

http://www.konceptanalytics.com/Researchreport/global-migraine-market-industry-analysis-outlook-2019-2023-41606.aspx

Koncept Analytics

Vikas Gupta

(Business Development Manager)

FFCS-36, Ansal Plaza

Vaishali, Ghaziabad

U.P - 201010

Tele: +91-120-4130959

Mobile: +91-9871694789

Mail ID – vikas@konceptanalytics.com

Contact
Vikas Gupta
vikas@konceptanalytics.com
+91-9871694789
End
Email:***@konceptanalytics.com
Posted By:***@konceptanalytics.com Email Verified
Tags:Global Migraine Market
Industry:Reports
Location:Delhi - Delhi - India
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share